Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate

被引:169
作者
Pecoits-Filho, R
Araújo, MRT
Lindholm, B
Stenvinkel, P
Abensur, H
Romao, JE
Marcondes, M
de Oliveira, AHF
Noronha, IL
机构
[1] Univ Sao Paulo, Sch Med, Renal Physiopathol Lab, Div Nephrol, BR-01246903 Sao Paulo, SP, Brazil
[2] Karolinska Inst, Div Baxter Novum, S-10401 Stockholm, Sweden
[3] Karolinska Inst, Div Renal Med, S-10401 Stockholm, Sweden
基金
巴西圣保罗研究基金会;
关键词
angiogenesis; IL-6; inflammation; peritoneal dialysis; peritoneal transport; VEGF;
D O I
10.1093/ndt/17.8.1480
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. It has been speculated that increased levels of circulating or intraperitoneal pro-inflammatory cytokines such as interleukin 6, and pro-angiogenic vascular endothelial growth factor (VEGF) may contribute to high peritoneal small-solute transport rate (PSTR) in continuous ambulatory peritoneal dialysis (CAPD) patients. In this study we evaluated possible relationships between plasma and dialysate IL-6 and VEGF levels and PSTR. Methods. Forty CAPD patients (mean age +/-SD of 58 +/- 14 years) with no apparent inflammation process or disease, who had been on CAPD for 19 +/- 15 months (range 3-56 months) were included in the study. Peritoneal equilibration test (PET) was used to evaluate PSTR. Patients were divided into two groups: high-average and high transporters (H/A; D/P(creat)greater than or equal to0.65) and low-average and low transporters (L/A; D/P-creat < 0.64). Albumin and IgG clearances were used in the evaluation of permeability to larger solutes. Plasma and overnight dialysate levels of IL-6 and VEGF were measured. Results. Plasma IL-6 (7.6 vs 4.3 pg/ml) and VEGF (342 vs 163 pg/ml) as well as dialysate IL-6 (174 vs 80 pg/ml) and VEGF (96 vs 69 pg/ml) levels were significantly higher in the H/A than in the L/A group. The dialysate appearance of IL-6 and VEGF correlated with D/P-creat, as well as with albumin and IgG clearances. Moreover, significant correlations were noted between dialysate IL-6 and dialysate VEGF levels. Conclusions. The findings of (i) increased plasma and dialysate levels of IL-6 and VEGF in the H/A group compared to the L/A group, (ii) an association between PSTR and both plasma and dialysate IL-6 and VEGF levels, and (iii) a significant correlation between dialysate IL-6 and VEGF concentrations suggest that inflammation, angiogenesis, and peritoneal transport may be interrelated and involved in the pathophysiology of high PSTR in CAPD patients. However, due to the cross-sectional design of this study, the cause and effect relationships between plasma and dialysate IL-6 and VEGF concentrations and high PSRT remain unclear.
引用
收藏
页码:1480 / 1486
页数:7
相关论文
共 30 条
[1]   Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction [J].
Ali, MH ;
Schlidt, SA ;
Chandel, NS ;
Hynes, KL ;
Schumacker, PT ;
Gewertz, BL .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 277 (05) :L1057-L1065
[2]   Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients [J].
Bologa, RM ;
Levine, DM ;
Parker, TS ;
Cheigh, JS ;
Serur, D ;
Stenzel, KH ;
Rubin, AL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (01) :107-114
[3]  
Chung SH, 2000, PERITON DIALYSIS INT, V20, P541
[4]  
Churchill DN, 1998, J AM SOC NEPHROL, V9, P1285
[5]  
Combet S, 2000, J AM SOC NEPHROL, V11, P717, DOI 10.1681/ASN.V114717
[6]  
Cooker LA, 2001, PERITON DIALYSIS INT, V21, pS102
[7]  
De Vriese AS, 2001, J AM SOC NEPHROL, V12, P1734, DOI 10.1681/ASN.V1281734
[8]   Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells [J].
Fee, D ;
Grzybicki, D ;
Dobbs, M ;
Ihyer, S ;
Clotfelter, J ;
Macvilay, S ;
Hart, MN ;
Sandor, M ;
Fabry, Z .
CYTOKINE, 2000, 12 (06) :655-665
[9]   Elevation of interleukin 6 in the dialysate reflects peritoneal stimuli and deterioration of peritoneal function [J].
Fujimori, A ;
Naito, H ;
Miyazaki, T ;
Azuma, M ;
Hashimoto, S ;
Horikawa, S ;
Tokukoda, Y .
NEPHRON, 1996, 74 (02) :471-472
[10]  
Griga T, 1999, HEPATO-GASTROENTEROL, V46, P920